Retatrutide

Retatrutide 10, 20 & 30 mg (Triple Receptor Agonist)

Retatrutide Canada research product available from Elev8 Lab in 10 mg, 20 mg, and 30 mg vial sizes. Retatrutide is an investigational triple-agonist peptide studied for activity at the GLP-1, GIP, and glucagon receptors, making it a distinct model for metabolic and multi-receptor signalling research.

Retatrutide Research Specifications

• Form: Lyophilized powder
• Scientific / alternate name: LY3437943
• Available vial sizes: 10 mg, 20 mg, 30 mg
• Research classification: Triple-receptor agonist
• Primary receptor targets: GLP-1, GIP, and glucagon receptors
• Testing: 10 mg sample lab report available below

Researchers continue to explore Retatrutide in controlled laboratory studies focused on cellular communication, peptide pharmacology, endocrine biology, and the mechanisms involved in energy homeostasis. Its multi-agonist profile provides a useful model for examining how several metabolic signaling pathways may interact within a single compound.

Retatrutide is also of interest in comparative research because its triple-agonist profile differs from more traditional single- and dual-receptor peptide models. This allows researchers to study how broader receptor activity may influence overall metabolic response within controlled experimental settings.

Interest in Retatrutide has grown quickly because of its distinctive triple-agonist design and its role in next-generation metabolic research. It continues to stand out in studies exploring how multiple signaling pathways can be targeted within a single compound.

For a side-by-side overview of related incretin research models, read our Semaglutide vs. Tirzepatide vs. Retatrutide comparison.

Related research: Explore how retatrutide and amylin-based signalling may complement one another in our Retatrutide and Cagrilintide Together guide.

Third-party testing: View the Retatrutide 10 mg Certificate of Analysis for the tested sample report. Available product variations on this page are 10 mg, 20 mg, and 30 mg.

For laboratory and research purposes only. Not intended for human or veterinary use, diagnosis, treatment, or consumption.